U.S. market Closed. Opens in 4 hours 53 minutes

DXCM | DexCom, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for DXCM we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is wealthy, Growth is exceptionally good and Health is strong.

Valuation (17%)

Company Industry
P/E Ratio (TTM) 41.84 41.98
PEG Ratio (TTM) 11.58 0.06
P/S Ratio (TTM) 7.12 6.31
P/B Ratio (TTM) 11.46 5.80
P/FCF Ratio (TTM) 42.09 39.59
Price to 5YR AVG Earnings Ratio 81.97 60.27
Price to 5YR AVG FCF Ratio 109.33 36.53

Profitability (70%)

Company Industry
ROA (TTM) 9.81% 4.71%
ROE (TTM) 29.58% 25.46%
Net Profit Margin (TTM) 16.95% 7.23%
ROIC 5YR AVG 10.62% 6.56%

Growth (97%)

4QTR AVG 3YR AVG 5YR AVG
EPS 17.73% 158.72% 131.05%
Revenue 4.02% 33.57% 28.81%
Net Income 17.91% 166.37% 135.68%
Cash Flow 20.31% 66.51% 52.53%

Health (65%)

Company Industry
Current Ratio (TTM) 2.82 2.62
Quick Ratio (TTM) 2.48 1.95
D/E Ratio (TTM) 1.01 0.55
Interest Coverage (TTM) 35.49 3.81
Piotroski F-Score 7 6
Altman Z-Score 5.65 7.10
LTL to 5YR AVG FCF 10.04 3.65
Shares Outstanding Growth 5YR AVG 1.83% 1.60%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙